Speak directly to the analyst to clarify any post sales queries you may have.
The veterinary reference laboratory market is experiencing robust transformation as industry leaders respond to the increasing complexity of diagnostics, adoption of cutting-edge technologies, and the need for cross-sector collaboration to meet the requirements of diverse animal health stakeholders.
Market Snapshot: Veterinary Reference Laboratory Market Growth
In 2024, the veterinary reference laboratory market achieved a value of USD 4.72 billion, with projections reaching USD 5.39 billion by 2025 and an anticipated USD 13.66 billion by 2032. This strong CAGR of 14.20% reflects sustained investment in advanced molecular testing and the emergence of digital pathology, both enabling laboratories to deliver more precise and efficient diagnostics for companion and livestock animals. Regulatory shifts and the integration of next-generation technologies are encouraging international collaboration and driving enhanced market participation across regions.
Scope & Segmentation
This report offers a comprehensive analysis of the veterinary reference laboratory market, spanning commercial, academic, and governmental contexts. Segmentation provides clarity on market drivers and assists senior decision-makers in identifying profitable opportunities and emerging risks within this evolving sector.
- Animal Types: Encompasses cattle, horses, cats, dogs, along with other livestock and companion animals, representing diagnostic diversity across clinical settings and contributing to broad application for laboratory services.
- Test Types: Covers microbiology, molecular diagnostics, pathology, and serology, each offering unique diagnostic perspectives to address a range of animal diseases and broaden laboratory capabilities.
- Technologies: Includes conventional diagnostics, immunoassays, mass spectrometry, and advanced molecular platforms, supporting both comprehensive disease detection and increased laboratory throughput.
- End Users: Incorporates academic institutions, commercial laboratories, and government bodies, each driving demand for tailored diagnostic solutions and supporting innovation through distinct organizational needs.
- Disease Types: Features genetic, hormonal, metabolic, and infectious diseases originating from bacterial, fungal, parasitic, or viral sources, highlighting the necessity for adaptable and responsive diagnostic protocols.
- Sample Types: Involves blood, feces, swabs, tissue, and urine, each essential for robust disease monitoring and efficient laboratory workflow across multiple animal populations.
- Regions: Analyzes Americas (including the U.S., Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe (U.K., Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland), Middle East (UAE, Saudi Arabia, Qatar, Turkey, Israel), Africa (South Africa, Nigeria, Egypt, Kenya), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan), offering thorough insight into geographical dynamics and regulatory climates influencing market development.
- Key Providers: Assesses the roles of IDEXX Laboratories, Zoetis, Covetrus, Heska Corporation, Neogen Corporation, Eurofins Scientific, and SYNLAB AG in driving market innovation and securing competitive advantage.
Key Takeaways for Senior Decision-Makers
- Advancements in digital pathology, high-throughput sequencing, and automation boost diagnostic accuracy, reduce turnaround times, and enable cost-effective laboratory operations.
- Collaborative initiatives between academic institutions, pharmaceutical companies, and IT vendors are strengthening data sharing, fostering resource integration, and expanding access to specialized expertise.
- Laboratory workflows are evolving to handle a wider array of sample types and animal populations, ensuring process optimization for both livestock and companion animal diagnostics.
- Regional variations in regulatory practices, logistics, and workforce access require tailored market entry and compliance strategies to maintain consistent diagnostic standards.
- The rise of digital infrastructures, such as laboratory information management systems, is streamlining operational scalability and supporting ongoing regulatory adaptation to meet changing industry standards.
Tariff Impact on Supply Chains and Costs
Recent U.S. tariff actions have required veterinary reference laboratories to reassess procurement and supply chain strategies, prompting organizations to diversify reagent sourcing and validate secondary suppliers. This shift enhances domestic partnerships and promotes greater supply chain resilience, although laboratories may need to update inventory control methods. The growing trend toward reagent miniaturization and use of on-instrument consumables further contributes to continuity of diagnostic operations and decreased dependency on imports.
Methodology & Data Sources
The report is developed using a combined approach of secondary research, in-depth interviews with industry professionals, and validation from expert panels. Rigorous data triangulation ensures that market trends are accurately represented, offering insight into clinical, operational, and strategic realities across all segments.
Why This Report Matters
- Delivers actionable intelligence for technology planning, risk management, and adaptability as industry regulations and client needs continue to evolve.
- Supports senior decision-makers with transparent segmentation, reliable regional insights, and comprehensive competitor intelligence aligned with executive priorities.
- Reveals approaches to optimize supply chains, develop skilled teams, and foster innovation toward long-term, sustainable market growth.
Conclusion
Aligning with technological progress and shifting stakeholder expectations allows laboratories to advance diagnostic quality, drive operational efficiency, and maintain strategic flexibility in a rapidly transforming market landscape.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Veterinary Reference Laboratory market report include:- IDEXX Laboratories, Inc.
- Zoetis Inc.
- Covetrus, Inc.
- Heska Corporation
- Neogen Corporation
- Eurofins Scientific S.E.
- SYNLAB AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 5.39 Billion |
| Forecasted Market Value ( USD | $ 13.66 Billion |
| Compound Annual Growth Rate | 14.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |


